Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Tokai Tokyo Research Forecasts Continued Growth for Matsumotokiyoshi
February 18, 2002
- Requirements for Biologic Products, Antibiotics Revised
February 18, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
February 18, 2002
- 30% Hike of Copayment Agreed
February 18, 2002
- Korosho to Review Drug Reevaluation System
February 18, 2002
- WORLD NEWS IN BIREF
February 18, 2002
- Mochida to Expand Its Business Fields
February 11, 2002
- LDP to Review Safety Measures against Medical Devices
February 11, 2002
- Sankyo to Beef Up Business Development in China
February 11, 2002
- Shimadzu: Multi-channel Oxygen Monitors
February 11, 2002
- WEBSITE NEWS
February 11, 2002
- Brand Generic Business Likely to Be Brisk
February 11, 2002
- BUSINESS NEWS IN BRIEF
February 11, 2002
- Wholesalers Concerned over Effects of Medical Fee Cut: JPPA
February 11, 2002
- Recovery of Business Performance Stressed by President: Tsumura
February 11, 2002
- Japanese Society of Process Chemistry Created
February 11, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
February 11, 2002
- Korosho Clarifies Marketing Approval System
February 11, 2002
- Good Results Obtained in Vascular Dementia PIII Study on Aricept: Int'l Congress
February 11, 2002
- Korosho Proposes to Reduce Re-pricing Ceiling from 25% to 15%
February 11, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…